CERMA, KRISIDA
 Distribuzione geografica
Continente #
NA - Nord America 292
EU - Europa 212
AS - Asia 66
OC - Oceania 1
SA - Sud America 1
Totale 572
Nazione #
US - Stati Uniti d'America 288
IE - Irlanda 54
GB - Regno Unito 48
IT - Italia 43
SE - Svezia 21
CN - Cina 20
HK - Hong Kong 20
DE - Germania 16
SG - Singapore 14
FI - Finlandia 9
FR - Francia 7
ID - Indonesia 6
CZ - Repubblica Ceca 4
LT - Lituania 4
BG - Bulgaria 3
CR - Costa Rica 3
IN - India 3
IL - Israele 2
PL - Polonia 2
AU - Australia 1
BR - Brasile 1
CA - Canada 1
RO - Romania 1
VN - Vietnam 1
Totale 572
Città #
Ashburn 57
Dublin 54
Fairfield 45
Chandler 32
Enfield 32
Seattle 21
Hong Kong 20
Nyköping 20
Woodbridge 17
Houston 16
Cambridge 11
Wilmington 11
New York 10
Singapore 9
Helsinki 8
Phoenix 7
Cardiff 6
Jakarta 6
Ann Arbor 5
San Diego 5
Savona 5
Beijing 4
Bologna 4
Bremen 4
Brno 4
Modena 4
Frankfurt am Main 3
London 3
Princeton 3
Reggio Emilia 3
Roncoferraro 3
San José 3
Shanghai 3
Sofia 3
Acton 2
Frattamaggiore 2
Guangzhou 2
Imola 2
Noicattaro 2
Norwalk 2
Palermo 2
Parma 2
Rome 2
Southend 2
Augusta 1
Bengaluru 1
Canberra 1
Edinburgh 1
Eugene 1
Falkenstein 1
Fiorenzuola D'arda 1
Fremont 1
Hammersmith 1
Hanoi 1
Iasi 1
Jerusalem 1
Lappeenranta 1
Manhattan 1
Manoppello 1
Munich 1
Nagold 1
Nanjing 1
New Orleans 1
Paris 1
Tel Aviv 1
Toronto 1
Vinhedo 1
Washington 1
Totale 485
Nome #
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 171
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 100
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 89
BRAF-mutated colorectal cancer: Clinical and molecular insights 69
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience. 68
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. 65
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 12
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 7
Totale 581
Categoria #
all - tutte 3.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 2 1 0 0 0
2020/2021113 2 0 0 26 62 1 0 7 4 5 4 2
2021/202288 4 16 2 0 4 2 5 9 5 6 28 7
2022/2023228 8 18 13 12 12 10 2 13 59 2 73 6
2023/2024141 12 9 9 17 12 10 14 15 5 3 14 21
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 581